Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
March 01 2022 - 5:20PM
Edgar (US Regulatory)
Free Writing Prospectus
Filed pursuant to Rule 433
Registration No. 333-263130
Pricing Term Sheet
(To preliminary prospectus supplement, dated March 1, 2022,
and prospectus, dated March 1, 2022)
$750,000,000
2.650% Notes due 2032
|
|
|
Issuer: |
|
CME Group Inc. |
|
|
Security Type: |
|
SEC Registered Senior Unsecured Notes |
|
|
Trade Date: |
|
March 1, 2022 |
|
|
Settlement Date: |
|
March 8, 2022 (T+5) |
|
|
Principal Amount: |
|
$750,000,000 |
|
|
Maturity Date: |
|
March 15, 2032 |
|
|
Interest Rate Per Annum: |
|
2.650% |
|
|
Interest Payment Dates: |
|
Semiannually, on March 15 and September 15 of each year |
|
|
First Interest Payment Date: |
|
September 15, 2022 (long first coupon) |
|
|
Optional Redemption: |
|
Make-whole redemption at any time prior to December 15, 2031 (three months prior to the maturity date of the notes) at a discount rate equal to the Treasury Rate (as defined in the preliminary prospectus supplement) plus 15
bps. Redemption at par at any time commencing on December 15, 2031. |
|
|
Public Offering Price: |
|
99.677% |
|
|
Proceeds to CME Group Inc. (before estimated expenses, after underwriting discount): |
|
$742,702,500 |
|
|
Treasury Benchmark: |
|
UST 1.875% due February 15, 2032 |
|
|
Treasury Benchmark Price and Yield: |
|
101-17 / 1.707% |
|
|
Re-offer Spread vs. Treasury Benchmark: |
|
98 bps |
|
|
Yield to Maturity: |
|
2.687% |
|
|
Mandatory Offer to Repurchase Notes: |
|
In the event of a Change of Control Triggering Event (as defined in the preliminary prospectus supplement) at 101% of the principal amount, plus accrued and unpaid interest. |
|
|
Day Count: |
|
30/360 |
|
|
Payment Business Days: |
|
New York |
|
|
Payment Convention: |
|
Following, Unadjusted |
|
|
Minimum Denomination / Multiples: |
|
$2,000 / $1,000 |
|
|
CUSIP / ISIN: |
|
12572QAK1 / US12572QAK13 |
|
|
Ratings*: |
|
Aa3 / AA- |
|
|
|
Joint Book-Running Managers: |
|
Barclays Capital Inc. BofA Securities, Inc.
BMO Capital Markets Corp. Citigroup Global Markets Inc.
J.P. Morgan Securities LLC Lloyds Securities Inc.
MUFG Securities Americas Inc. TD Securities (USA) LLC
Wells Fargo Securities, LLC |
|
|
Co-Managers: |
|
Loop Capital Markets LLC U.S. Bancorp
Investments, Inc. Credit Suisse Securities (USA) LLC Deutsche
Bank Securities Inc. Goldman Sachs & Co. LLC BNP
Paribas Securities Corp. Siebert Williams Shank & Co., LLC
Academy Securities, Inc. |
* Note: A securities rating is not a recommendation to buy, sell, or hold securities and may be subject to revision or
withdrawal at any time.
** It is expected that delivery of the notes will be made against payment therefor on or about March 8, 2022, which is
the fifth business day following the date hereof (such settlement cycle being referred to as T+5). Under Rule 15c6-1 under the Exchange Act of 1934, as amended, trades in the secondary market are
generally required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade such notes more than two business days prior to the scheduled settlement date will be
required, by virtue of the fact that the notes initially will settle in T+5, to specify an alternative settlement arrangement at the time of any such trade to prevent failed settlement. Purchasers of such notes who wish to trade notes prior to the
date of delivery should consult their advisors.
The issuer has filed a registration statement (including a prospectus) with the Securities and
Exchange Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the Securities and Exchange Commission for more
complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the Securities and Exchange Commissions website at www.sec.gov. Alternatively, the issuer or any underwriter
participating in this offering can arrange to send you the prospectus supplement and accompanying prospectus if you request it by calling Barclays Capital Inc. toll free at 1-888-603-5847 or by calling BofA Securities, Inc. toll free at 1-800-294-1322.
CME (NASDAQ:CME)
Historical Stock Chart
From Jun 2024 to Jul 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Jul 2023 to Jul 2024